Compounds > gusperimus
Page last updated: 2024-08-23

gusperimus and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

gusperimus has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balabanov, S; Braig, M; Brümmendorf, TH; Chahoud, T; Hauber, J; Kolodzik, A; Meier, C; Pällman, N; Panse, J; Rarey, M; Schröder, M; Wiehle, V; Wilhelm, T; Ziegler, P; Ziegler, S1

Other Studies

1 other study(ies) available for gusperimus and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias.
    Investigational new drugs, 2012, Volume: 30, Issue:6

    Topics: Animals; Antigens, CD34; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Guanidines; Humans; Hydrazones; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Oxidoreductases Acting on CH-NH Group Donors

2012